| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,935 | 43,477 | 39,917 | 50,660 | | Cost of Revenue | 24,431 | 27,761 | 35,569 | 25,919 | | | Gross Profit | 14,504 | 15,716 | 4,348 | 24,741 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,962 | 13,794 | 4,500 | 21,983 | | Non Recurring | 148 | 197 | 5,341 | 46,722 | | Others | 1,754 | 1,783 | 1,832 | 1,912 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (360) | (58) | (7,325) | (45,876) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15 | 21 | 54 | 135 | | Earnings Before Interest And Taxes | (345) | (37) | (7,271) | (45,741) | | Interest Expense | 537 | 956 | 647 | 1,375 | | Income Before Tax | (882) | (993) | (7,918) | (47,116) | | Income Tax Expense | (249) | (256) | (1,210) | 18,509 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (633) | (737) | (6,708) | (65,625) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (633) | (737) | (6,708) | (65,625) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($633) | ($737) | ($6,708) | ($65,625) |
|
0.12% Nasdaq 
0.01 (0.81%) 
Income Statement
